Zibetti Dal Molin, Graziela
Abrahão, Carina Meira
Coleman, Robert L.
Maluf, Fernando Cotait
Article History
Received: 12 January 2018
Accepted: 29 July 2018
First Online: 18 August 2018
Ethics approval and consent to participate
: Ethics approval was obtained from the ethics committee’s of Hospital Beneficencia Portuguesa de Sao Paulo.We had consent to participate under the ‘Ethics, consent and permissions’ heading.
: We obtained consent to publish from the legal parent to report individual patient data.
: RLC has clinical research funding from Merck, AstraZeneca/Medimmune, Genentech/Roche, Novartis, Clovis Oncology, Abbvie, and Janssen pharmaceuticals. All other authors have no competing interests to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.